Imbruvica Shows Response in 2/3 of Steroid Dependent, Refractory cGVHD Patients in Phase II Study December 22, 2016Vol.39 No.11
Tagrisso Shows Superiority vs. Chemo in EGFR T790M Mutation-Positive Disease December 22, 2016Vol.39 No.11
Drugs & Targets Keytruda becomes first anti-PD-1 therapy to receive a CHMP positive opinion for previously untreated NSCLC December 16, 2016Vol.42 No.46
Obama Signs Cures Act, Funding Biden’s Moonshot and Boosting NIH, NCI, FDA Budgets Over 10 Years December 16, 2016Vol.42 No.46By Matthew Bin Han Ong
